Individuals who have relied solely on AI to identify mushrooms have become sick and hospitalized after eating a wild mushroom the AI mistakenly disclosed as safe to eat.
Earlier last week, Amazon (NASDAQ: AMZN) announced its fourth-quarter results that surpassed market expectations. It has recently launched several GenAI applications, the latest one being Rufus, a genAI shopping assistant. Its stock hit a 52-week high following its result announcement. Amazon's Financials Amazon's fourth quarter revenues grew 14% to $170 billion, ahead of the market's forecast of $166.2 billion. Net income increased to $10.6 billion or $1 per share, compared with net income of $0.3 billion, or $0.3 per share a year ago. Analysts estimated income of $0.8 per share. By segment, net product sales grew 8.7% to $76.7 billion and net service sales increased 18.5% to $93.3 billion. North American sales grew 13% to $105.5 billion, while international sales grew 16.5% to $40.2 billion. Revenues from Amazon Web Services (AWS) increased 13% to $24.2 billion in line with analyst estimates. Advertising services revenue grew a strong 27% to $14.6 billion primarily